BidaskClub upgraded shares of Mylan N.V. (NASDAQ:MYL) from a sell rating to a hold rating in a research note released on Tuesday.

Several other research firms have also recently issued reports on MYL. UBS AG reissued a buy rating and issued a $46.00 price objective (down from $50.00) on shares of Mylan N.V. in a research report on Thursday, August 10th. Citigroup Inc. raised shares of Mylan N.V. from a neutral rating to a buy rating and raised their target price for the stock from $36.00 to $42.00 in a research report on Wednesday, August 16th. Mizuho reaffirmed a buy rating and set a $37.00 price target (down previously from $53.00) on shares of Mylan N.V. in a research note on Sunday, August 20th. BMO Capital Markets reaffirmed a buy rating and set a $45.00 price target on shares of Mylan N.V. in a research note on Friday, September 29th. Finally, ValuEngine raised shares of Mylan N.V. from a hold rating to a buy rating in a research note on Monday. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the stock. The stock has an average rating of Buy and an average price target of $41.87.

Shares of Mylan N.V. (NASDAQ:MYL) traded up 18.17% during mid-day trading on Tuesday, reaching $38.44. 10,941,945 shares of the company’s stock traded hands. Mylan N.V. has a 12-month low of $29.39 and a 12-month high of $45.87. The firm has a market capitalization of $20.61 billion, a price-to-earnings ratio of 31.08 and a beta of 1.30. The stock has a 50-day moving average price of $31.43 and a 200 day moving average price of $36.46.

Mylan N.V. (NASDAQ:MYL) last posted its quarterly earnings results on Wednesday, August 9th. The company reported $1.10 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.18 by ($0.08). The company had revenue of $2.96 billion during the quarter, compared to analysts’ expectations of $3 billion. Mylan N.V. had a return on equity of 22.42% and a net margin of 5.51%. The company’s quarterly revenue was up 15.7% on a year-over-year basis. During the same period in the prior year, the business earned $1.16 EPS. Analysts anticipate that Mylan N.V. will post $4.52 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this piece can be viewed at https://www.thecerbatgem.com/2017/10/04/mylan-n-v-myl-upgraded-by-bidaskclub-to-hold.html.

A number of large investors have recently bought and sold shares of MYL. Wellington Management Group LLP grew its holdings in Mylan N.V. by 2.6% in the first quarter. Wellington Management Group LLP now owns 46,373,108 shares of the company’s stock worth $1,808,088,000 after purchasing an additional 1,165,852 shares during the last quarter. BlackRock Inc. increased its position in shares of Mylan N.V. by 4.5% during the second quarter. BlackRock Inc. now owns 40,574,158 shares of the company’s stock worth $1,575,089,000 after purchasing an additional 1,751,515 shares in the last quarter. Vanguard Group Inc. increased its position in shares of Mylan N.V. by 12.0% during the second quarter. Vanguard Group Inc. now owns 32,880,790 shares of the company’s stock worth $1,276,432,000 after purchasing an additional 3,531,974 shares in the last quarter. State Street Corp increased its position in shares of Mylan N.V. by 1.6% during the second quarter. State Street Corp now owns 20,498,541 shares of the company’s stock worth $795,751,000 after purchasing an additional 321,977 shares in the last quarter. Finally, Pzena Investment Management LLC increased its position in shares of Mylan N.V. by 69.9% during the second quarter. Pzena Investment Management LLC now owns 12,339,687 shares of the company’s stock worth $479,027,000 after purchasing an additional 5,077,371 shares in the last quarter. 71.97% of the stock is owned by institutional investors.

Mylan N.V. Company Profile

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Analyst Recommendations for Mylan N.V. (NASDAQ:MYL)

Receive News & Stock Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related stocks with our FREE daily email newsletter.